Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DESappear Study: Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization

NCT02869087 is registered in ClinicalTrials.gov with Elixir Medical Corporation as lead sponsor.

NCT NCT02869087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02869087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DESappear Study: Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization
Lead sponsor
Elixir Medical Corporation
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2016
Completion date
April 30, 2021
Enrollment
21 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular disease